[1] BARCELLINI A,ROCCIO M,LALISCIA C,et al.Endometrial cancer:when upfront surgery is not an option[J].Oncology,2021,99(2):65-71.
[2] ZHANG M,LIU Y,HOU S,et al.KDM4B,a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma[J].Mol Omics,2022,18(6):506-519.
[3] DUAN Q,ZHANG H,ZHENG J,et al.Turning cold into hot:firing up the tumor microenvironment[J].Trends Cancer,2020,6(7):605-618.
[4] ZHANG F,GUO J,ZHANG Z,et al.Mesenchymal stem cell-derived exosome:a tumor regulator and carrier for targeted tumor therapy[J].Cancer Lett,2022,526:29-40.
[5] BEJARANO L,JORDȂO M J C,JOYCE J A.Therapeutic targeting of the tumor microenvironment[J].Cancer Discov,2021,11(4):933-959.
[6] ARNETH B.Tumor microenvironment[J].Medicina(Kaunas),2019,56(1):15.
[7] XIAO Y,YU D.Tumor microenvironment as a therapeutic target in cancer[J].Pharmacol Ther,2021,221:107753.
[8] GU Y,WU X,ZHANG J,et al.The evolving landscape of N6-methyladenosine modification in the tumor microenvironment[J].Mol Ther,2021,29(5):1703-1715.
[9] YANG J,LI H,HU S,et al.ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma:implication for COVID-19[J].Aging(Albany NY),2020,12(8):6518-6535.
[10] WANG P,ZENG Z,SHEN X,et al.Identification of a multi-RNA-type-based signature for recurrence-free survival prediction in patients with uterine corpus endometrial carcinoma[J].DNA Cell Biol,2020,39(4):615-630.
[11] RIERA-DOMINGO C,AUDIGÉ A,GRANJA S,et al.Immunity,hypoxia,and metabolism-the ménage à trois of cancer:implications for immunotherapy[J].Physiol Rev,2020,100(1):1-102.
[12] WANG Y,WANG Y,REN Y,et al.Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer[J].Semin Cancer Biol,2022,86(Pt 3):542-565.
[13] LIU Y,WANG M,DENG T,et al.Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ[J].Cancer Biol Med,2022,19(9):1301-1314.
[14] MIYAI Y,SUGIYAMA D,HASE T,et al.Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade[J].Life Sci Alliance,2022,5(6):e202101230.
[15] ZHENG A,YUAN F,LI Y,et al.Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus[J].J Virol,2007,81(22):12465-12471.
[16] MEERTENS L,BERTAUX C,CUKIERMAN L,et al.The tight junction proteins claudin-1,-6,and-9 are entry cofactors for hepatitis C virus[J].J Virol,2008,82(7):3555-3560.
[17] ZHU J,WANG R,CAO H,et al.Expression of claudin-5,-7,-8 and-9 in cervical carcinoma tissues and adjacent non-neoplastic tissues[J].Int J Clin Exp Pathol,2015,8(8):9479-9486.
[18] HONG L,WU Y,FENG J,et al.Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytomas[J].Hum Pathol,2014,45(12):2423-2429.
[19] ZAVALA-ZENDEJAS V E,TORRES-MARTINEZ A C,SALAS-MORALES B,et al.Claudin-6,7,or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness,migration,and proliferation rate[J].Cancer Invest,2011,29(1):1-11. |